Legend Free Cash Flow from 2010 to 2024
LEGN Stock | USD 47.45 0.39 0.83% |
Free Cash Flow | First Reported 2019-03-31 | Previous Quarter -66.3 M | Current Value -118.7 M | Quarterly Volatility 42.4 M |
Check Legend BiotechCorp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Legend main balance sheet or income statement drivers, such as Tax Provision of 268.9 K, Interest Expense of 22.9 M or Selling General Administrative of 112.1 M, as well as many exotic indicators such as Price To Sales Ratio of 70.16, Dividend Yield of 0.0 or PTB Ratio of 8.04. Legend financial statements analysis is a perfect complement when working with Legend BiotechCorp Valuation or Volatility modules.
Legend | Free Cash Flow |
Latest Legend BiotechCorp's Free Cash Flow Growth Pattern
Below is the plot of the Free Cash Flow of Legend BiotechCorp over the last few years. It is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets. Legend BiotechCorp's Free Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Legend BiotechCorp's overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow | 10 Years Trend |
|
Free Cash Flow |
Timeline |
Legend Free Cash Flow Regression Statistics
Arithmetic Mean | 48,693,773 | |
Geometric Mean | 282,376,954 | |
Coefficient Of Variation | 647.13 | |
Mean Deviation | 285,560,672 | |
Median | 286,661,000 | |
Standard Deviation | 315,111,895 | |
Sample Variance | 99295.5T | |
Range | 792.6M | |
R-Value | (0.88) | |
Mean Square Error | 24739.3T | |
R-Squared | 0.77 | |
Significance | 0.000018 | |
Slope | (61,775,121) | |
Total Sum of Squares | 1390137.1T |
Legend Free Cash Flow History
Other Fundumenentals of Legend BiotechCorp
Legend BiotechCorp Free Cash Flow component correlations
About Legend BiotechCorp Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Legend BiotechCorp income statement, its balance sheet, and the statement of cash flows. Legend BiotechCorp investors use historical funamental indicators, such as Legend BiotechCorp's Free Cash Flow, to determine how well the company is positioned to perform in the future. Although Legend BiotechCorp investors may use each financial statement separately, they are all related. The changes in Legend BiotechCorp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Legend BiotechCorp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Legend BiotechCorp Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Legend BiotechCorp. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Free Cash Flow | -506 M | -480.7 M | |
Free Cash Flow Yield | (0.05) | (0.05) | |
Free Cash Flow Per Share | (2.87) | (2.73) | |
EV To Free Cash Flow | (19.06) | (20.02) | |
Price To Free Cash Flows Ratio | (20.94) | (21.99) | |
Free Cash Flow Operating Cash Flow Ratio | 1.32 | 0.98 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Legend BiotechCorp Correlation against competitors. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Legend Stock analysis
When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.94) | Revenue Per Share 1.619 | Quarterly Revenue Growth 1.876 | Return On Assets (0.17) | Return On Equity (0.52) |
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.